Psychiatry and Neurology, Neurology · Houston, TX
NPI
1003846619
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6410 Fannin St Ste 1014
Houston, TX, 77030
Phone (832) 325-7080
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,403 services
Medicare patients, 2024
67
Average age 65
Drug cost, 2024
$2.6M
1,760 prescriptions
Company payments, 2025
$14K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John W Lindsey was code 99214 (office e&m - established), 90 times for 56 patients. In total John W Lindsey billed 1,403 services in 15 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 90 | 56 | $77.23 | $6,951 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 48 | 39 | $12.01 | $576 |
| 99215 Office E&M - Established | Office | 17 | 15 | $128.93 | $2,192 |
By year: 2022 $187K for 3,871 services; 2023 $123K for 2,530 services; 2024 $67K for 1,403 services.
Medicare prescription drug claims, 2024
In 2024, the drug John W Lindsey prescribed most often to Medicare patients was Baclofen, with 194 prescriptions and refills. In total John W Lindsey wrote 1,760 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 194 | 376 | 50 | $5,468 |
| Gabapentin Generic | 179 | 352 | 48 | $5,060 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 87 | 219 | 22 | $2,059 |
| Dalfampridine Er Dalfampridine | 78 | 141 | 17 | $109K |
| Duloxetine Hcl Generic | 56 | 108 | 14 | $1,129 |
| Levetiracetam Generic | 55 | 105 | 12 | $797 |
| Tizanidine Hcl Generic | 53 | 91 | 15 | $1,352 |
| Kesimpta Pen Ofatumumab | 51 | 51 | Under 11 | $464K |
| Carbamazepine Er Carbamazepine | 43 | 76 | 11 | $6,339 |
| Teriflunomide Generic | 41 | 53 | Under 11 | $89K |
| Pregabalin Generic | 37 | 61 | Under 11 | $1,148 |
| Zolpidem Tartrate Generic | 35 | 37 | Under 11 | $312 |
| Memantine Hcl Generic | 35 | 60 | Under 11 | $612 |
| Clonazepam Generic | 34 | 36 | Under 11 | $145 |
| Modafinil Generic | 34 | 74 | Under 11 | $2,919 |
Brand drugs: 238 claims; generic drugs: 1,522 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John W Lindsey $14K ($14K in general payments such as food, travel and fees) from 13 companies. The largest payer was Pfizer Inc. with $9,036.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 3 | $9,036 |
| EMD Serono, Inc. MRK.DE | 10 | $3,715 |
| TG Therapeutics, Inc. TGTX | 7 | $253 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $192 |
| Celgene Corporation BMY | 6 | $118 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $113 |
| Biogen, Inc. BIIB | 3 | $90.45 |
| Genentech USA, Inc. ROG.SW | 2 | $75.65 |
| Amgen Inc. AMGN | 2 | $56.03 |
| Genzyme Corporation SNY | 1 | $23.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.